×
About 11,863 results

ALLMedicine™ Aortic Stenosis Center

Research & Reviews  4,182 results

Effects of statins after transcatheter aortic valve implantation in key patient populat...
https://doi.org/10.1097/FJC.0000000000001114
Journal of Cardiovascular Pharmacology; Fischer-Rasokat U, Renker M et. al.

Jul 30th, 2021 - Statin therapy after transcatheter aortic valve replacement (TAVI) is associated with better short- and long-term outcomes. It is of interest to identify specific patient populations that might profit from statin therapy. In this retrospective, ob...

Impact of Systolic Blood Pressure on Heart Failure Symptoms With Moderate Aortic Stenosis.
https://doi.org/10.1016/j.amjcard.2021.06.018
The American Journal of Cardiology; Maeda M, Omori T et. al.

Jul 29th, 2021 - In patients with moderate aortic stenosis (AS), heart failure (HF) symptoms are often unrelated to the AS severity, and the causes of HF symptoms are often unclear. Hypertension is known as one of the most common comorbidities in degenerative AS. ...

Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcath...
https://doi.org/10.1161/JAHA.120.020599
Journal of the American Heart Association; Venturi G, Pighi M et. al.

Jul 27th, 2021 - Background The impact of staged versus concomitant coronary procedures on renal function in patients with aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) remains unclear. Methods and Results Three-hundred thirty-nine pati...

Comparison of transcarotid versus transapical transcatheter aortic valve implantation o...
https://doi.org/10.5603/CJ.a2021.0071
Cardiology Journal; Hudziak D, Targoński R et. al.

Jul 27th, 2021 - The purpose of this study was to compare the safety and clinical outcomes of transcarotid (TC) and transapical access (TA) transcatheter aortic valve implantation (TAVI) patients whom the transfemoral approach (TF) was not feasible. The analysis i...

Prosthesis-patient mismatch affects late survival after valve surgery for severe aortic...
https://doi.org/10.23736/S0021-9509.21.11786-0
The Journal of Cardiovascular Surgery; Swinkels BM, Ten Berg JM et. al.

Jul 27th, 2021 - The effect of prosthesis-patient mismatch (PPM) on late survival after aortic valve replacement (AVR) in patient with symptomatic severe aortic stenosis (AS) remains unclear. Also, late follow-up in previous studies is confined to only one decade....

see more →

Guidelines  3 results

The Rationale for Performance of Coronary Angiography and Stenting Before Transcatheter...
https://doi.org/10.1016/j.jcin.2016.09.024
JACC. Cardiovascular Interventions; Ramee S, Anwaruddin S et. al.

Dec 10th, 2016 - Transcatheter aortic valve replacement (TAVR) is an effective, nonsurgical treatment option for patients with severe aortic stenosis. The optimal treatment strategy for treating concomitant coronary artery disease (CAD) has not been tested prospec...

Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR.
https://doi.org/10.1016/j.jcmg.2014.12.014
JACC. Cardiovascular Imaging; Hahn RT, Little SH et. al.

Mar 17th, 2015 - Recent multicenter trials have shown that transcatheter aortic valve replacement is an alternative to surgery in a high risk population of patients with severe, symptomatic aortic stenosis. Echocardiography and multislice computed tomographic imag...

Transcatheter aortic valve replacement program development: recommendations for best pr...
https://doi.org/10.1002/ccd.25529
Catheterization and Cardiovascular Interventions : Offici... Hawkey MC, Lauck SB et. al.

Apr 25th, 2014 - Transcatheter aortic valve replacement (TAVR) is an increasingly available therapy for the management of aortic stenosis in higher risk populations. Beyond addressing the procedural challenges, centers must attend to the unique requirements of dev...

see more →

Drugs  10 results see all →

Clinicaltrials.gov  131 results

FlexNav EU CE Mark Study
https://clinicaltrials.gov/ct2/show/NCT03724812

Apr 28th, 2020 - The FlexNav European Union (EU) study will be conducted as a prospective, multi-center, single-arm investigational study. Up to 200 high or extreme risk patients with symptomatic, severe native aortic stenosis who are determined by an independent ...

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
https://clinicaltrials.gov/ct2/show/NCT01240902

Apr 22nd, 2020 - The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for aortic valve surgery and/or very high risk for...

Frailty in Elderly Patients Receiving Surgical or Percutaneous Procedures for Valvular Disorders
https://clinicaltrials.gov/ct2/show/NCT03365453

Mar 30th, 2020 - This is a prospective study. This a single centre study involving the Maria Cecilia Hospital (Ravenna, Italy). The study is expected to enroll at least 450 consecutive patients with ≥70 years, which are admitted for: GROUP A: severe aortic stenosi...

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
https://clinicaltrials.gov/ct2/show/NCT03315832

Mar 18th, 2020 - Aortic stenosis (AS) is the most frequent valvular heart disease in Western countries, with increasing prevalence. Recent guidelines recommend aortic valve intervention (surgical aortic valve replacement [SAVR] or transcatheter aortic valve replac...

The Aortic Valve DECalcification (AVADEC) Trial
https://clinicaltrials.gov/ct2/show/NCT03243890

Mar 5th, 2020 - Aortic stenosis is a common heart valve disease and due to the growing elderly population the prevalence is increasing. The disease is progressive with increasing calcification of the valve cusps. A few attempts with medical preventive treatment h...

see more →

News  415 results

TAVI Safe and Effective in Patients With Inflammatory Bowel Disease
https://www.medscape.com/viewarticle/954929

Jul 19th, 2021 - NEW YORK (Reuters Health) - Transcatheter aortic-valve implantation (TAVI) is safe and effective for patients with inflammatory bowel disease (IBD), according to what is believed to be the first study to assess TAVI outcomes in this patient popula...

LDCT Lung Cancer Screening May ID Aortic Stenosis Risk
https://www.medscape.com/viewarticle/952981

Jun 11th, 2021 - Using low-dose computed tomography (LDCT) to screen for aortic valve calcification during a lung cancer screening could identify those at risk for aortic stenosis, says new research published in Annals of Internal Medicine. Aortic stenosis is one ...

TVT Registry: Favorable TAVR Outcomes in Low-risk Bicuspid Patients
https://www.medscape.com/viewarticle/952007

May 27th, 2021 - Transcatheter aortic valve replacement (TAVR) in bicuspid anatomy provides outcomes roughly similar to those with tricuspid aortic stenosis among patients at low surgical risk, a large national registry suggests. "Despite concerns about TAVR in bi...

ATLANTIS Hints at How to Choose Post-TAVR Antithrombotics
https://www.medscape.com/viewarticle/951234

May 15th, 2021 - UPDATED May 16, 2021 // Use of transcatheter aortic valve replacement/implantation (TAVR or TAVI) swiftly expanded from the high surgical risk to the low surgical risk settings, the necessary clinical trials following one after the other. But a go...

New AHA Statement on Aortic Stenosis in Chronic Kidney Disease
https://www.medscape.com/viewarticle/951086

May 13th, 2021 - The evaluation and management of aortic stenosis (AS) in patients with chronic kidney disease (CKD) is complex and clinically challenging and requires a multidisciplinary heart-kidney team-based approach, the American Heart Association (AHA) says ...

see more →

Patient Education  4 results see all →